Rosalie Patricio
Family Medicine · Santa Paula, CANPI 1467547877
Payments from drug & device makers
Across 336 payments — averaging $21.33 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$1K
- Boehringer Ingelheim$743
- AbbVie$739
- AstraZeneca$674
- Pfizer$525
- Bayer$350
- plus $3K from 30 others
What the payments were for
- Food & beverage$7,166100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 63 | $1,262 |
| Boehringer Ingelheim | 31 | $743 |
| AbbVie(2 entities) | 36 | $739 |
| AstraZeneca | 33 | $674 |
| Pfizer | 31 | $525 |
| Bayer | 13 | $350 |
| Lilly USA, LLC | 17 | $347 |
| Sanofi-aventis U.S. LLC | 12 | $288 |
| Amgen | 10 | $242 |
| Biohaven Pharmaceuticals, Inc. | 8 | $237 |
| Mylan Specialty L.p. | 10 | $184 |
| Merck | 7 | $149 |
| GSK | 6 | $132 |
| Inspire Medical Systems, Inc. | 1 | $120 |
| Phadia US Inc. | 4 | $119 |
| Johnson & Johnson | 12 | $118 |
| Abbott | 5 | $115 |
| Stryker | 1 | $105 |
| Exact Sciences | 5 | $92 |
| Biohaven Pharmaceutical Holding Company Ltd. | 4 | $72 |
| Novartis | 4 | $70 |
| Sunovion Pharmaceuticals Inc. | 5 | $61 |
| Endogastric Solutions, Inc | 1 | $52 |
| Dynavax Technologies Corporation | 2 | $50 |
| Soleno Therapeutics, Inc. | 2 | $45 |
| Verrica Pharmaceuticals Inc. | 2 | $41 |
| Regeneron Healthcare Solutions, Inc. | 1 | $38 |
| Otsuka America Pharmaceutical, Inc. | 2 | $33 |
| Bioventus LLC | 1 | $29 |
| Boston Scientific | 1 | $28 |
| Eisai Inc. | 1 | $20 |
| Hologic Sales And Service, LLC | 1 | $18 |
| Amarin Pharma, Inc. | 1 | $18 |
| Cranial Technologies, Inc | 1 | $18 |
| Dexcom, Inc. | 1 | $17 |
| Sanofi Pasteur Inc. | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$7,166 in reported general payments places this provider in the 90th percentile of 10,533 family medicine providers in California.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| JardianceEmpagliflozin | 82 | $123,940 |
| JanuviaSitagliptin Phosphate | 39 | $43,703 |
| EliquisApixaban | 28 | $36,618 |
| Tresiba Flextouch U-100Insulin Degludec | 29 | $20,114 |
| XareltoRivaroxaban | 14 | $16,186 |
| OzempicSemaglutide | 15 | $16,004 |
| Tresiba Flextouch U-200Insulin Degludec | 11 | $6,824 |
| Breo ElliptaFluticasone/Vilanterol | 13 | $4,658 |
| VascepaIcosapent Ethyl | 14 | $4,417 |
| Levothyroxine Sodium | 210 | $2,111 |
| Rosuvastatin Calcium | 120 | $1,952 |
| Gabapentin | 87 | $1,152 |
| Atorvastatin Calcium | 188 | $1,015 |
| Metformin Hcl | 233 | $979 |
| Nano 2nd Gen Pen NeedlePen Needle, Diabetic | 15 | $901 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Boehringer IngelheimJardiance | $743 | $123,94082 claims |
| MerckJanuvia | $149 | $43,70339 claims |
| PfizerEliquis | $525 | $36,61828 claims |
| Johnson & JohnsonXarelto | $118 | $16,18614 claims |
| Novo NordiskOzempic | $1,262 | $16,00415 claims |
| GSKBreo Ellipta | $132 | $4,65813 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 10,533 family medicine providers in California.
Other family medicine in Santa Paula
- Amina HaggagNorthridge$112.8M
- Steven ReynoldsLong Beach$53M
- Rizwana MohseniLake Forest$26.7M
- Daniel JohnsonSan Diego$15.7M
- Stacey LayleSan Diego$14.8M
- Apinya VutikullirdCypress$14.3M
- Hanid AudishSpring Valley$13.6M
- Augusto FocilOxnard$12.6M
- Jack VuLong Beach$10.1M
- Suzanne FussellOxnard$8.9M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.